Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels-Reference-Cited by-同舟云学术

Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels

Published:2023-01-18 Issue:5 Volume:18 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Zhou An‐Min¹,Wang Meng‐Meng¹,Su Yan¹²^ORCID,Yu Zheng‐Hong²,Liu Hong‐Ke¹,Su Zhi¹^ORCID

Affiliation:

1. Jiangsu Collaborative Innovation Center of Biomedical Functional Materials College of Chemistry and Materials Science Nanjing Normal University Nanjing 210023 P. R. China

2. Department of Rheumatology and Immunology Jinling Hospital Medical School of Nanjing University Nanjing 210002 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200614

Reference33 articles.

1. Erasers of Histone Acetylation: The Histone Deacetylase Enzymes

2. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

3. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

4. Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy;Bioorganic Chemistry;2024-06

2. HDAC-an important target for improving tumor radiotherapy resistance;Frontiers in Oncology;2023-07-12

3. The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy;Cancers;2023-04-10